$9.29
-0.31[-3.23%]
At close: May 17
$9.29
0[0.00%]
After Hours: 4:00PM EDT
Theravance Biopharma
(NASDAQ:TBPH)Theravance Biopharma Stock (NASDAQ:TBPH), Earnings Estimates, EPS, and Revenue
Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS
$-0.090
Quarterly Revenue
$14.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$61.5M
Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma | -$0.13 | — | — | — | $13.75M | — | — | — | 08/05/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.24 | -$0.25 | -$0.09 | 64.00% | $10.42M | $13.96M | $14.50M | 3.89% | 05/13/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.15 | -$0.15 | -$0.17 | -13.33% | $14.65M | $17.68M | $17.57M | -0.65% | 02/26/2024 | Get Alert |
| TBPH | Theravance Biopharma | -$0.21 | -$0.21 | -$0.17 | 19.05% | $12.45M | $15.00M | $15.69M | 4.62% | 11/07/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.04 | -$0.16 | -$0.13 | 18.75% | $11.05M | $15.24M | $13.75M | -9.78% | 08/07/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.33 | -$0.26 | -$0.24 | 7.69% | $13.20M | $13.84M | $10.42M | -24.73% | 05/08/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.18 | -$0.17 | -$0.21 | -23.53% | $14.95M | $15.73M | $14.65M | -6.87% | 02/27/2023 | Get Alert |
| TBPH | Theravance Biopharma | -$0.46 | -$0.18 | -$0.21 | -16.67% | $13.19M | $12.05M | $12.45M | 3.33% | 11/07/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$0.80 | -$0.03 | -$0.04 | -33.33% | $12.91M | $12.41M | $11.05M | -10.96% | 08/04/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$1.24 | -$0.11 | -$0.22 | -100.00% | $14.26M | $14.48M | $13.20M | -8.87% | 05/05/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$0.92 | -$0.33 | -$0.18 | 45.45% | $18.73M | $13.48M | $14.95M | 10.87% | 02/23/2022 | Get Alert |
| TBPH | Theravance Biopharma | -$1.16 | -$0.55 | -$0.46 | 16.36% | $18.26M | $14.69M | $13.19M | -10.18% | 11/03/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.00 | -$1.01 | -$0.80 | 20.79% | $15.01M | $15.41M | $12.91M | -16.20% | 08/03/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.14 | -$1.05 | -$1.24 | -18.10% | $19.86M | $17.27M | $14.26M | -17.45% | 05/04/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.17 | -$1.02 | -$0.92 | 9.80% | $29.50M | $20.85M | $18.73M | -10.17% | 02/23/2021 | Get Alert |
| TBPH | Theravance Biopharma | -$1.05 | -$0.97 | -$1.16 | -19.59% | $12.43M | $18.58M | $18.26M | -1.74% | 11/05/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$0.72 | $0.98 | -$1.00 | -202.04% | $26.15M | $19.64M | $15.01M | -23.58% | 08/06/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$1.32 | -$1.07 | -$1.14 | -6.54% | $5.34M | $18.13M | $19.86M | 9.55% | 05/06/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$0.92 | -$1.13 | -$1.17 | -3.54% | $15.74M | $16.84M | $29.50M | 75.17% | 02/24/2020 | Get Alert |
| TBPH | Theravance Biopharma | -$1.10 | -$1.11 | -$1.05 | 5.41% | $12.84M | $11.62M | $12.43M | 6.94% | 11/05/2019 | Get Alert |
| TBPH | Theravance Biopharma | -$0.76 | -$1.24 | -$0.72 | 41.94% | $23.48M | $10.87M | $26.15M | 140.57% | 07/31/2019 | Get Alert |
FAQ
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma (TBPH) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?
The Actual EPS was $-0.09, which beat the estimate of $-0.25.
What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?
The Actual Revenue was $14.5M, which beat the estimate of $14M.
Browse earnings estimates, EPS, and revenue on all stocks.